Allena Pharmaceuticals
ALNA
ALNA was delisted on the 7th of September, 2022.
36 hedge funds and large institutions have $18M invested in Allena Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 3 closing their positions.
275% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 4
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
24% more funds holding
Funds holding: 29 → 36 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
36% less capital invested
Capital invested by funds: $28.1M → $18M (-$10.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$1.05M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$231K |
| 3 |
State Street
Boston,
Massachusetts
|
+$167K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$150K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$81.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.9M |
| 2 |
Renaissance Technologies
New York
|
-$556K |
| 3 |
Millennium Management
New York
|
-$244K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$113K |
| 5 |
Bank of New York Mellon
New York
|
-$44K |
ALNA Hedge Fund Activity: Q3 2021 in Review
36 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q3 2021, worth a combined $18M — down 36% from $28.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ALNA positions and 3 closed out — a net gain of 7 holders — while 15 added to existing stakes and 4 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $1.05M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $3.9M sold.
- 36 institutional investors held Allena Pharmaceuticals (ALNA) as of Q3 2021, up from 29 in Q2 2021.
- Funds reported $18M of Allena Pharmaceuticals stock for Q3 2021, down 36% quarter-over-quarter.
- 10 funds opened new Allena Pharmaceuticals positions in Q3 2021 and 3 closed out, a net change of +7 holders.
- The largest Allena Pharmaceuticals buyer in Q3 2021 was Altium Capital Management, an estimated $1.05M added.
- The largest Allena Pharmaceuticals seller in Q3 2021 was Point72 Asset Management, an estimated $3.9M sold.
Based on aggregated 13F filings for Q3 2021.